
UnitedHealth: Lagging, But An Upbeat 2026 Outlook Helps Clear The Path
Seeking Alpha
公開日時: Sep 15, 2026, 09:28 AM
Mike Zaccardi, CFA, CMT 9.74K Followers Follow Summary UnitedHealth Group (UNH) remains a buy, with attractive valuation and solid fundamentals despite recent underperformance versus the S&P 500. Q2 results delivered an earnings triple play: beats on revenue and EPS, plus raised FY 2026 guidance; medical loss ratio held at 86.7%. Consensus EPS upgrades (24 upgrades, zero downgrades) and a 6.9% FCF yield support confidence in UNH’s long-term growth trajectory. Technicals are mixed: primary trend is bullish, but a breakdown below $370 could trigger a downside move toward $320; key support in mid-$350s. JHVEPhoto/iStock Editorial via Getty Images The Health Care sector of the S&P 500 began outperforming in the middle of the summer, but it didn’t get much help from one of its largest components. UnitedHealth Group ( UNH ) is down This article was written by Mike Zaccardi, CFA, CMT 9.74K Followers Follow Freelance Financial Writer | Investments | Markets | Personal Finance | RetirementI create written content used in various formats including articles, blogs, emails, and social media for financial advisors and investment firms in a cost-efficient way. My passion is putting a narrative to financial data. Working with teams that include senior editors, investment strategists, marketing managers, data analysts, and executives, I contribute ideas to help make content relevant, accessible, and measurable. Having expertise in thematic investing, market events, client education, and compelling investment outlooks, I relate to everyday investors in a pithy way. I enjoy analyzing stock market sectors, ETFs, economic data, and broad market conditions, then producing snackable content for various audiences. Macro drivers of asset classes such as stocks, bonds, commodities, currencies, and crypto excite me. My thing is communicating finance with an educational and creative style. I also believe in producing evidence-based narratives using empirical data to drive home points. Charts are one of the many tools I leverage to tell a story in a simple but engaging way. I focus on SEO and specific style guides when appropriate. Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Source: Seeking Alpha
個別の投資に関する推奨やアドバイスを提供することを意図しておりません。ここで述べられている意見や見解は、あくまでも各記事の個人的見解です。